<?xml version="1.0" encoding="UTF-8"?>
<ack id="cas14841-sec-0018">
 <title>ACKNOWLEDGMENTS</title>
 <p>We thank our patients and medical and technical staff, especially Ms Hiromi Nakano. A list of participating institutions to TR is given in the Appendix 
  <xref rid="cas14841-sup-0002" ref-type="supplementary-material">S2</xref>. This work was supported by the Tokyo Cooperative Oncology Group with funding from Taiho Pharmaceutical Co. Ltd., Japan [no grant number] under the study contract, and partly supported by a grant from the Project for Development of Innovative Research on Cancer Therapeutics (P‐DIRECT) [grant number 11110018] and the Project for Cancer Research and Therapeutic Evolution (P‐CREATE) [grant number 16770660] by the Japan Agency for Medical Research and Development.
 </p>
</ack>
